ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $2.08M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
7
Holding in Top 10
–
Calls
$3.83M
Puts
$2.3M
Top Sellers
| 1 | -$769K | |
| 2 | -$489K | |
| 3 | -$316K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$181K |
| 5 |
Morgan Stanley
New York
|
-$167K |